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Objective: Previously we identiﬁed palmitoyl-lysophosphatidylcholine (LPC 16:0), as well as linoleoyl-,
arachidonoyl- and oleoyl-LPC (LPC 18:2, 20:4 and 18:1) as the most prominent LPC species generated by
the action of endothelial lipase (EL) on high-density lipoprotein (HDL). In the present study, the impact
of EL and EL-generated LPC on interleukin-8 (IL-8) synthesis was examined in vitro in primary human
aortic endothelial cells (HAEC) and in mice.
Methods and Results: Adenovirus-mediated overexpression of the catalytically active EL, but not its
inactive mutant, increased endothelial synthesis of IL-8 mRNA and protein in a time- and HDL-
concentration-dependent manner. While LPC 18:2 was inactive, LPC 16:0, 18:1 and 20:4 promoted IL-8
mRNA- and protein-synthesis, differing in potencies and kinetics. The effects of all tested LPC on IL-8
synthesis were completely abrogated by addition of BSA and chelation of intracellular Ca2+. Underlying
signaling pathways also included NFkB, p38-MAPK, ERK, PKC and PKA. In mice, adenovirus-mediateddenovirus
cyl-chain
overexpression of EL caused an elevation in the plasma levels of MIP-2 (murine IL-8 analogue) accompa-
nied by a markedly increased plasma LPC/PC ratio. Intravenously injected LPC also raised MIP-2 plasma
concentration, however to a lesser extent than EL overexpression.
Conclusion: Our results indicate that EL and EL-generated LPC, except of LPC 18:2, promote endothelial
IL-8 synthesis, with different efﬁcacy and kinetics, related to acyl-chain length and degree of saturation.
pacit
d be cAccordingly, due to its ca
chemokine IL-8, EL shoul
. Introduction
EL is a member of the triglyceride (TG) lipase gene family local-
zed on the surface of vascular endothelial cells [1,2]. By virtue of its
hospholipase activity, EL cleaves HDL-phosphatidylcholine (HDL-
C) liberating free fatty acids (FFA) and lysophosphatidylcholine
LPC) [3,4]. Experiments in genetically modiﬁed mice, either over-
Abbreviations: LPC, lysophosphatidylcholine; EL, endothelial lipase; 16:0
PC, palmitoyl-lysophosphatidylcholine; 18:2 LPC, linoleoyl-LPC; 20:4 LPC,
rachidonoyl-LPC; 18:1 LPC, oleoyl-LPC; HAEC, human aortic endothelial cells; AA,
rachidonic acid; NEFA, nonesteriﬁed fatty acids; FFA, free fatty acids; BSA, bovine
erum albumin; PKA, protein kinase A; PKC, protein kinase C; NFB, nuclear factor
appaB; 2-AG, 2-arachidonoyl-glycerol; p38-MAPK, p38-mitogen-activatedprotein
inase; ERK, extracellular regulated kinase; HDL, high-density lipoprotein; MIP-2,
acrophage inﬂammatory protein 2-alpha; GFX, GF109203X.
∗ Corresponding author. Tel.: +43 316 380 4194; fax: +43 316 380 9615.
E-mail address: sasa.frank@medunigraz.at (S. Frank).
021-9150 © 2010 Elsevier Ireland Ltd. 
oi:10.1016/j.atherosclerosis.2010.11.007
Open access under CC BY-NC-ND license.y to modulate the availability of the pro-inﬂammatory and pro-adhesive
onsidered an important player in the development of atherosclerosis.
© 2010 Elsevier Ireland Ltd. 
expressing or lacking functional EL revealed an inverse relationship
between plasma HDL cholesterol level and EL expression [5,6]. The
capacity of EL to decrease HDL plasma concentrations together
with its ability to promote monocyte adhesion to endothelial cells
[7], suggest EL to be an atherogenic enzyme. However, the results
obtained fromatherosclerosis studies using EL knock out (ko)mod-
elswere conﬂicting,withdecreasedaortic atherosclerosis indouble
EL-/apoE-ko mice [8] and no differences in a separate study where
both EL-/apoE-ko and EL-/LDL receptor-ko mice were used [9].
In a previous study, we demonstrated that in addition to the
well characterized 1-palmitoyl (16:0) LPC, EL generates substantial
amounts of unsaturated LPC 18:1, 18:2 and 20:4, respectively [10].
Saturated 16:0 LPC represents the well characterized standard LPC,
Open access under CC BY-NC-ND license.shown to inducevarious signalingpathways therebypromoting the
production of inﬂammatory molecules, including IL-8, in human
vascular endothelial cells [11].
The physiological concentrations of LPC in body ﬂuids ranges
between100and170M[12]with evenmillimolar levels inhyper-
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ipidemic subjects [13]. LPC in plasma are distributed between
lbumin and other carrier serum proteins and lipoproteins [14,15].
urthermore, free LPC may transiently exist due to an excessive
ipolysis when the concentrations of FFA and LPC locally exceed
he binding capacity of albumin and carrier proteins [15].
Interleukin-8 (IL-8) is a pro-inﬂammatory chemokine which
cts as an important chemoattractant for neutrophils and
onocytes, and has been implicated in the pathogenesis of
therosclerosis [16]. It is synthesized by various types of vascu-
ar cells, including endothelial cells, where inﬂammatory stimuli
nd bioactive lipids have been shown to augment its production
11,17].
Since studies investigating the impact of LPC on endothelial
hemokine secretion used exclusively 16:0 LPC [11,18] nothing is
nown about the impact of length and degree of saturation of the
PC-acyl chain on IL-8 production in vascular endothelial cells, the
ain source of EL.
Therefore, the aim of the present study was to determine the
ffect of EL on the generation of IL-8 and to compare the impact
f the “standard” 16:0 LPC with that of unsaturated LPC, abun-
antly generated by EL, on IL-8 production in primary human aortic
ndothelial cells (HAEC) and in vivo in mice.
. Materials and methods
.1. LPC
LPC 16:0, 18:1, 18:2 and 20:4 were purchased from Avanti
olar Lipids. LPC were dissolved and stored at −20 ◦C in chloro-
orm/methanol under argon atmosphere. Required amounts of LPC
ere dried under a stream of nitrogen or argon and re-dissolved in
BS (pH 7.4) for cell culture experiments or in pyrogen-free saline
NaCl) for in vivo experiments.
.2. Cell culture
Human primary aortic endothelial cells (HAEC) were obtained
rom Lonza and maintained in endothelial cell growth medium
EGM-MV Bullet Kit = EBM medium+growth supplements + FCS
Lonza)] supplemented with 50 IU/ml penicillin, and 50g/ml
treptomycin. Cellswere cultured in gelatine-coated dishes at 37 ◦C
n a 5% CO2 humidiﬁed atmosphere and were used for experiments
rom passage 5 to 10. Cells were seeded (75000/well) in 12-well
lates 48h before exposure to HDL or LPC.
.3. Isolation of human HDL
HDL (subclass 3, d=1.125–1.21g/ml) was prepared by sequen-
ial ultracentrifugation of plasma obtained from normolipidemic
lood donors as described previously [19].
.4. Adenovirus generation
Adenoviruses (Ad) encoding human EL (EL), catalytically inac-
ive mutant EL (MUT) containing Asp192 →Asn substitution and
acterial-galactosidase (LacZ)werepreparedexactly asdescribed
reviously [19].
.5. Adenoviral infection of HAEC
HAEC (75,000/well) were seeded in 12-well plates. Forty-eight
ours later, conﬂuent cells were infected with EL-Ad, EL-MUT-Ad
r LacZ-Ad at multiplicity of infection (MOI) of 50 in endothelial
asalmedium(EBM)without fetal calf serum(FCS). Followinga2h-
nfection period, cells were grown in complete EBM for additional
4h. Thereafter, cells were washed with PBS and incubated withsis 214 (2011) 338–344 339
EBMmediumwithout supplements andwithout serum for 3h. This
medium is referred to as a serum-freemedium throughout the text.
Thereafter, medium was removed and replaced with fresh serum-
free medium supplemented with indicated concentrations of HDL.
2.6. LPC treatment of HAEC
2.6.1. LPC cytotoxycity:
Initial time- and concentration-dependent experiments
revealed that in a serum-free medium in the absence of bovine
serum albumin (BSA) all tested LPC at concentrations up to 10M
were not toxic to HAEC (for incubations up to 8h), as determined
by monitoring the release of lactate dehydrogenase (LDH), using a
cytotoxicity detection kit (LDH) (Roche, Mannheim, Germany).
2.6.2. Experiments under serum-free conditions:
48h after plating, cells were washed with PBS, and incubated
in serum-free medium for 3h. Thereafter, medium was removed
and replaced with fresh serum-free medium supplemented with
different concentrations of LPC. In some experiments as indicated
in the respective ﬁgure legends, LPC were applied along with BSA
at a molar ratio of 1:1 and 5:1, respectively.
2.6.3. Experiments in the presence of serum:
Here, washing steps and preincubation steps with serum-free
medium were omitted. Due to the presence of BSA and other bind-
ing proteins in serum, 100M LPC was applied for the incubation
in serum-containingmedium (5%) (to ascertain the presence of free
LPC).
Medium was collected in pre-chilled tubes following exposure
to HDL or LPC, centrifuged and used for lactate dehydrogenase
(LDH) assay and IL-8 quantiﬁcation. Cells were washed with PBS
and lysed for RNA or protein isolation.
2.7. Pharmacological inhibitors
HAEC were pre-treated with respective pharmacological
inhibitors or vehicle (DMSO) for 45min in serum-containing
medium before the addition of fresh FCS-medium contain-
ing LPC. Following inhibitors were applied: Bapta/AM (Ca2+
chelator; 10M), PDTC (NFB inhibitor; 30M), SB203580 (p38-
MAPK inhibitor; 5M), PD98059 (ERK inhibitor; 30M), GFX
(PKC inhibitor; 1M), H-89 (PKA inhibitor; 10M), genis-
tein/daizein (tyrosin kinase inhibitor/negative control; 100M),
U-73122/U73343 (PLC inhibitor/negative control; 2M each). For
treatment with pertussis toxin (PTX) cells were preincubated with
0.1g/ml PTX for 17h. All inhibitors were from Sigma.
2.8. Quantitative real-time PCR (qRT-PCR)
Please see Supplemental Methods.
2.9. Western blotting
EL expression was examined exactly as described [19]. Please
see supplemental Methods for details.
2.10. IL-8 and MIP-2 measurements by ELISA
IL-8 was measured in cell culture media by an ELISA Kit (eBio-
science, San Diego, USA) according to the manufacturer’s protocol.
Protein content of cell culture wells was initially determined to be
equal for all treatments.
MIP-2, a mouse IL-8 analogue, was measured in mouse
plasma by an ELISA Kit according to manufacturers instructions
(Komabiotech, Seoul, Korea).
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Fig. 1. Overexpression of EL induces IL-8mRNA and protein expression. LacZ or EL-overexpressing HAECwere incubated in a serum-freemediumwith 100g/ml HDL for the
indicated time periods. Subsequently, (A) IL-8 mRNA content was determined by qRT-PCR and (B) IL-8 protein secretion was assessed in cell supernatants by ELISA. Results
shown are mean± SEM of one representative experiment performed in triplicates out of 3 experiments. (C) As in (B) except that HAEC were incubated with 100g/ml and
300g/ml HDL for 24h. (D) As in (B) except that in addition to LacZ and EL a catalytically inactive form of EL (MUT) was expressed in HAEC and incubated with HDL for 3h.
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n HAEC infected with LacZ-, EL- and MUT-Ad.
.11. Experiments in mice
.11.1. Intravenous (i.v.) injection of adenovirus
10–12weeks oldmaleC57Bl/6Jmice (5per group)were injected
ith3×109 particles of LacZ- or EL-Ad in100l of 0.9%NaCl via tail
ein injection. Six hours later, bloodwas collected from the retroor-
ital plexus into EDTA-containing tubes and centrifuged. Plasma
as storedat−70 ◦CbeforeanalysisofMIP-2or lipidextraction. The
fﬁciency of EL-overexpression was estimated indirectly by mea-
uringHDL-cholesterol plasmaconcentration,whichwasmarkedly
ecreased (>50%) in EL-Ad but unaltered in LacZ-Ad injected ani-
als (data not shown).
.11.2. Injection of LPC
Following a 6 h-fasting period, 10–12 weeks old male C57Bl/6J
ice (4–7 per group) were treated with 20mg/kg LPC in 0.9%
aCl (or NaCl alone) via tail vein injection. Five hours later,
lood was collected from the retroorbital plexus, centrifuged
mmediately and stored at −70 ◦C for measurements of MIP-
. For both adenovirus- and LPC-vein injection as well as for
lood collection, mice were anaesthetized with Isoﬂurane (Phar-
acia & Upjohn SA, Guyancourt, France). Animal experiments
ere approved by the Austrian Ministry of Education, Science
nd Culture according to the regulations for animal experimenta-
ion.ated with HDL for 3h. (F) Western blot analysis of EL and MUT as well as of ß-actin
2.12. Lipid extraction, HPLC and Mass Spectrometry
100l of mouse plasma was extracted according to Bligh
and Dyer [20] and analysed by HPLC and mass spectrometry
(supplemental Methods).
2.13. Statistical analysis
Cell culture experiments were performed at least three times
and values are expressed as mean plus SEM. Statistical signiﬁcance
was determined by the Student’s unpaired t-test (two-tailed) and
with application of Welch’s correction, where required. Group dif-
ferences were considered signiﬁcant for p<0.05 (*), p<0.01 (**),
and p<0.001 (***).
3. Experimental results
3.1. EL-generated lipids promote IL-8 expression in HAEC
Adenovirus mediated overexpression of EL and subsequent
incubation with HDL increased IL-8 mRNA content in HAEC, with
the strongest (5-fold) increase detected 1h after HDL addition
(Fig. 1A). As shown in Fig. 1B, the EL-expressing cells secreted
signiﬁcantly more (1.2-, 1.7- and 2.4-fold, respectively) IL-8 pro-
tein, at all tested time points (3, 8 and 24h, respectively), than
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edium containing either 50M(equimolar) or 8.8M(∼10Mfree LPC) BSA for 1
n Section 2. Results shown are mean± SEM of one representative experiment perfo
acZ control cells. Secreted IL-8 mass correlated directly with HDL-
oncentration (Fig. 1C). Enzymatically inactive EL (MUT), expressed
t similar level as EL (Fig. 1F), failed to raise IL-8protein (Fig. 1D) and
L-8 mRNA (Fig. 1E), respectively, arguing for the role of EL-derived
ipids in IL-8 upregulation.
.2. EL-generated LPC promote IL-8 expression in HAEC
Next we tested the capacity of LPC 16:0, 18:1, 18:2 and 20:4 to
nduce IL-8 expression. While LPC 16:0 and 18:1 elicited a maxi-
al 5- and 2-fold, respectively, increase in IL-8 mRNA after 1h of
ncubation, a maximal 3-fold upregulation was observed at 5h of
ncubation with LPC 20:4. LPC 18:2 had no effect on IL-8 mRNA
xpression (Fig. 2A). The observed LPC-mediated upregulation of
L-8mRNAcouldbecompletely abolisheduponadditionof equimo-
ar amounts of NEFA-free BSA (50M NEFA-free BSA+50M LPC)
Fig. 2B). However, when based on the assumption that one mol
f BSA binds 5mol of LPC [21] the BSA concentration was adjusted
o yield roughly 10M of free LPC (8.8M NEFA-free BSA+50M
PC), the upregulation of IL-8 mRNA could be restored (Fig. 2B).
While the 16:0 LPC-elicited IL-8 protein secretion was maxi-
ally increased (2.6-fold) after 3h, a maximal 18:1 LPC-elicited
ncrease (1.3-fold) was achieved after 8h. In contrast, the 20:4 LPC-
licited IL-8 protein secretion was signiﬁcantly increased after 5h
1.9-fold) and 8h (2.9-fold), respectively (Fig. 2C).
.3. LPC-elicited IL-8 mRNA upregulation is dependent on
ntracellular Ca2+ and NFB
Since 16:0 LPC is known to activate different signaling path-
ays [11,22], we examined whether the tested LPC differ in the
ctivation of signaling pathways underlying IL-8 mRNA upregula-
ion. As shown in Fig. 3A, the Ca2+ chelator Bapta/AM completely
bolished the effect of all LPC on IL-8 mRNA levels. Similarly, the
FB-inhibitor PDTC partially attenuated the effects of all testeded with 100M LPC in medium containing 5% FCS for the indicated time points,
n in supernatants by ELISA. (B) HAEC were incubated with 50M LPC in serum-free
sequently, relative IL-8mRNA abundancewas determined by qRT-PCR as described
in triplicates out of 3 experiments.
LPC on IL-8 mRNA (albeit statistically signiﬁcant only for 16:0 LPC)
(Fig. 3A).
The inhibitors of p38-MAPK (SB203580), ERK (PD98059), PKC
(GFX) and PKA (H-89) reduced the stimulatory effects of all tested
LPC; however, they also led to a constitutive reduction in con-
trol cells (Fig. 3B). The inhibition of tyrosin-kinases (genistein) and
phospholipase C (U-73122) did not have any effect on the IL-8
mRNA upregulation by all tested LPC as compared to the respec-
tive negative control inhibitors (daizein and U-73343) (data not
shown). Similarly, pertussis toxin (PTX), an inhibitor of the Gi/o-
proteins failed to affect the upregulation of IL-8 mRNA by all tested
LPC (suppl. Fig. 1).
3.4. EL-derived LPC promote the expression of MIP-2 in vivo
To demonstrate the capacity of EL to elicit expression of IL-8
in vivo, MIP-2 (a mouse analogue of IL-8) was measured in mice
upon adenovirus-mediated EL overexpression. As shown in Fig. 4A,
the MIP-2 plasma concentrations were signiﬁcantly higher in
EL-overexpressing mice compared with lacZ control mice. Impor-
tantly, the LPC/PC ratio was markedly higher in EL than in lacZ
control mice (Fig. 4B), clearly demonstrating an efﬁcient genera-
tion of EL-derived LPC in vivo. Taken together, these results strongly
argue for the role of EL-derived LPC in MIP-2 upregulation. Indeed,
as depicted in Fig. 4C, although not statistically signiﬁcant com-
pared with NaCl controls, MIP-2 plasma values were also increased
inmice treatedwith single LPC,whereby the effects of LPC 16:0 and
20:4 were slightly more pronounced than that of LPC 18:1.
4. DiscussionIn the present study, we investigated the role of EL and the most
prominent EL-generated LPC in the modulation of endothelial IL-8
expression. To our knowledge, no study has so far addressed the
effect of EL and LPC other than 16:0 LPC, on the endothelial pro-
duction of IL-8. The fact that only enzymatically active EL induced
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y qRT-PCR as described in Section 2. Results shown are mean± SEM of one repres
hat HAEC were preincubated with ERK inhibitor (PD98), p38-MAPK inhibitor (SB20
L-8mRNAandprotein inHAEC clearly implicates the EL-generated
leavage products of HDL-phospholipids in IL-8 induction. Since
FA are well known to induce IL-8 expression in endothelial cells
23], the present study focused on the impact of EL-generated
PC.
The LPC concentration of 10M in the absence of serum or
00M in the presence of 5% FCS used in our study was within the
patho)physiological range of 100M–1.7mM [12,13] and identi-
al to conditions in previous studies examining the impact of LPC
6:0 on the inﬂammatory response in vascular endothelial cells
11,18]. In linewith previous ﬁndings [11], 16:0 LPC elicited a rapid
nd pronounced upregulation of IL-8 mRNA. The 18:1 LPC-elicited
L-8 mRNA induction was also rapid; however, compared with that
f 16:0 LPC this effect was much less pronounced, and resulted in a
elayed increase in IL-8 protein secretion, which became obvious
nly after 5–8h of incubation. The observed delay in IL-8 protein
ecretion, relative to IL-8 mRNA upregulation might possibly be
ue to prior protein storage in secretory organelles as described by
nipe et al. [24].
ig. 4. Adenovirus mediated EL-overexpression and i.v. injected LPC induce MIP-2 (IL-8
h after i.v. injection of 3×109 virus particles of LacZ- or EL-Ad. MIP-2 plasma values
epresentative experiment (with 5 animals per group) out of 2 experiments. (B) Plasma
xpressed as a ratio of total LPC and PC species. Values are mean± SEM of a representa
h fasting period, 8–12 mice per group were injected via tail vein with either 20mg/k
ollected from the retroorbital plexus into tubes containing EDTA, followed by immediat
f 2 experiments.ith an intracellular Ca2+-chelator (Bapta A/M), a speciﬁc NFkB inhibitor (PDTC) or
aining 5% FCS for 1h. Subsequently, relative IL-8 mRNA abundance was determined
ive experiment performed in duplicates out of 3 experiments. (B) As in (A) except
KC inhibitor (GFX).
In contrast to a rapid, short-lived IL-8 mRNA increase elicited
with the LPC 16:0 and 18:1, the 20:4 LPC-elicited IL-8 mRNA
increase was slow-developing and time-dependent, accompanied
by a delayed onset of IL-8 protein secretion (Fig. 2A and C). Con-
sidering the potency of oxidized phospholipids to induce IL-8, we
testedwhether the observed, slow-developing 20:4 LPC-elicited IL-
8 response reﬂects the actionof oxidized20:4 LPCgeneratedduring
the incubation period [25]. As the effect of 20:4 LPC on IL-8 mRNA
induction could not be prevented by coincubation with the antiox-
idant Trolox, oxidative modiﬁcation of 20:4 LPC was not likely to
account for the observed kinetics of IL-8 increase (Suppl. Fig. 2).
Alternatively, the slow-developing 20:4 LPC effect on IL-8 expres-
sion might be explained by the action of slow-emerging metabolic
conversionproducts of 20:4 LPC, like arachidonic acid (AA), thepre-
cursor of eicosanoids, capable ofmodulating IL-8 expression [26] or
2-arachidonoyl-glycerol (2-AG) capable of affecting IL-8 expression
as well [27].
In line with the capacity of LPC 16:0, 18:1 and 20:4 [28] to
increase intracellular Ca2+ and to activate NFB [29], we identiﬁed
analogue) in mouse plasma. (A) Blood was collected from fed, male C57Bl/6J mice,
were determined by ELISA as described in Section 2. Values are mean± SEM of a
LPC and PC contents of mice described in (A) were determined by LC–MS/MS and
tive experiment (with 5 animals per group) out of 2 experiments. (C) Following a
g LPC in a total volume of 100l NaCl or NaCl alone. Five hours later, blood was
e centrifugation for the determination of MIP-2 in plasma. Results are mean± SEM
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crucial role for cytosolic Ca2+ and NFB in IL-8 induction. The dif-
erences in IL-8 regulation might reﬂect the acyl-chain dependent
apability of LPC to increase cytosolic Ca2+, as found in our recent
tudy [28]. Since inhibition of p38-MAPK, ERK, PKC and PKA also
ed to a constitutive reduction of IL-8 in control cells, the respec-
ive pathways rather seem to be involved in the basal response and
ight only play a minor role in the LPC-mediated IL-8 induction.
onsidering a delayed 20:4 LPC-mediated IL-8 mRNA upregulation
e also tested the effects of inhibitors at 4h. While the impact of
38-MAPK- and ERK-inhibition at 4h was similar to that observed
t 1h (Fig. 3B), other tested inhibitors were either detrimental to
AEC, or like PDTC (NFB inhibitor), markedly induced IL-8 mRNA
n control cells (not shown). Accordingly, the impact of inhibitors
ould not be addressed conclusively at 4h of incubation.
In contrast to previous ﬁndings [11] PTX failed to alter the
mpact of the tested LPC on IL-8 (suppl. Fig. 1). This might be due to
more pronounced contribution of PTX-sensitive pathways to LPC
ignaling in microvascular endothelial cells than in HAEC [11].
The tested LPC increased the plasma levels of MIP-2, a mouse
omolog of IL-8, however, without reaching statistical signiﬁcance.
he reason might be a too low plasma concentration of applied LPC
esulting in complete binding and neutralization by serumproteins
nd consequently reduced bioavailability of the free unbound form,
prerequisite for theirbiological effects including IL-8upregulation
11,30] (Fig. 2B).
In contrast to injected LPC, adenovirus-mediated EL overexpres-
ion in mice led to a signiﬁcant increase in MIP-2 accompanied by
marked increase of the LPC/PC ratio in mouse plasma. The more
rofound effect of EL overexpression as compared to single LPC on
IP-2plasma levelsmightbeexplainedbya sustainedEL-mediated
rovision of a mixture of LPC but also FFA, which are established
nducers of IL-8. Additionally, due to excessive EL-mediated lipoly-
is a high plasma concentration of lipolytic products (LPC and FFA)
ight lead to a saturation of lipid binding domains on albumin and
ther plasma carrier proteins, yielding increased concentrations of
he free LPC, which are capable of triggering biological effects.
Herewe show that EL induces endothelial IL-8 expression by the
eneration of lipolytic products during the enzymatic cleavage of
DL phospholipids. Themost prominent EL-generated lipids tested
n our study, LPC 16:0, 18:1, 18:2 and 20:4 exhibited different, acyl-
hain relatedpotencies andkinetics of IL-8 induction, dependenton
ntracellularCa2+ andpartiallyonNFB. In contrast to in vitroexper-
ments, where IL-8 upregulation reﬂected response of vascular
ndothelial cells to EL-lipids, upregulated plasma MIP-2 reﬂected
he induction of various cell types responsive to EL-derived LPC
and FFA).
Taken together, it is conceivable that attenuation of EL-activity,
ould be a promising strategy for the prevention and treatment of
PC-triggered inﬂammatory processes in the vasculature.
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